Conmed
This article was originally published in The Gray Sheet
Executive Summary
Firm's Linvatec subsidiary gains 510(k) clearance to market the Endopearl bioabsorbable device to enhance fixation of soft tissue grafts within the femoral socket during reconstruction of the anterior cruciate ligament